YC W23
Persist AI
Developing long-lasting drug formulations 50% faster
About
It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.
Founders
- Karthik Raman
- Christopher Shelner
Family Office Investors
2 deals trackedAltss has tracked family office activity in Persist AI. Investors shown are from our private markets database.
- Paul McCoy Family Office
- Purdue University Investment Fund
Industry & Focus
HealthcareDrug Discovery and DeliveryMachine LearningRoboticsMicrofluidicsNanotechnologyTherapeutics